4 - RASI's in Recommended Higher Target Doses May Lower Risk of Death and Kidney Failure in Octogenarians with HFrEF

First Author: Ali Ahmed, MD, MPH, Washington DC Veterans Medical Center
Second Author: Paul Heidenreich, MD, Stanford University
Third Author: Wilbert Aronow, MD, New York Medical College
Fourth Author: Richard Allman, MD, George Washington University
Fifth Author: Charles Faselis, MD, Washington DC VA Medical Center
Sixth Author: Mo-kyung Sin, PhD, RN, FGSA, FAAN, Seattle University
Seventh Author: Phillip Lam, MD, Georgetown University
Eighth Author: Gregg Fonarow, MD, UCLA Cardiology